Social Security beneficiaries will be getting a hefty cost-of-living raise next year, which may temporarily ease their anxiety over a new report warning of the program’s fast-approaching insolvency.

With the White House pushing Congress to allow the government to negotiate drug pricing, Big Pharma wonders, Where’s the love?

Recent research suggests that postponing my retirement might be good for my aging brain.

A fraught battle with our 4-year-old grandson over screen time has forced Grandma and Grandpa to admit that his customary weekly visits may now hold less allure for him — and us — than they once did.

For reasons both political and pecuniary, attempts to expand Medicare benefits have always been a tough sell, despite the rising demands of an aging population. As Congress prepares to give it another shot, I’m hedging my bets.

At a time when impaired vision among the senior set is beginning to alarm some public-health experts, a surprising change in my own eyesight has me scrambling to get a better view of things.

Raging wildfires and other sources of airborne pollution are threatening more than our respiratory and circulatory systems. New research is strengthening the link between air quality and dementia.

Concerned that they may be called upon to provide full-time caregiving someday if a late-life romance leads to cohabitating, many older couples are choosing to follow their hearts — while maintaining separate residences.

With my hearing aids on the fritz, I suddenly find myself rooting for scientists seeking a way to genetically manipulate the malfunctioning human ear.

The “deprescribing” movement faces various obstacles as advocates seek to gain some influence amid our drug-happy healthcare system, not the least of which is simply getting your doctor’s attention.

If stress can lead to graying hair, can periods of calm reverse the process? Recent research suggests it may have that effect, though my graying locks are probably beyond help.

Late-blooming runners are routinely beating veteran racers at the national level, raising questions about the toll decades of training exact on the body — and why we choose to run (or not) in the first place.

The controversy surrounding the FDA’s approval of the first new Alzheimer’s drug in nearly two decades will do little to temper demand by desperate patients and their caregivers. It may also exacerbate racial disparities among those vying for the treatment.

Emerging from social isolation, I’m discovering the importance of patience and empathy while gradually reconnecting to friends, family, and an eerily familiar postpandemic world.

The pandemic has persuaded the U.S. healthcare industry to reimagine some aspects of its operations in ways that may yield significant benefits for the elderly. Will those revelations survive a return to normalcy?

Cases of the debilitating neurological disease have been surging in recent years and some researchers suggest COVID-19 may accelerate the trend.

Memories of a former colleague — and recent research — remind me that an upbeat view of aging may pay healthy dividends well into our later years.

Navigating the Medicare enrollment process should be easy. It is not.

Financial stress during middle age can create physical pain in your later years, according to a new study. My own family’s experience suggests healing is possible.

COVID has drawn fresh attention to our broken long-term-care system, sparking some ambitious government initiatives. But recent research suggests there’s much more work to be done.

The latest thinking on Alzheimer’s disease suggests we may slow its development with diet and lifestyle shifts, but a recent harrowing experience has me wondering whether my brain is already too far gone — or if I just need to pay better attention to what I’m doing.